Notman Donald

Average Profitability
9.75%
Insider Buys Quantity
3
Insider Buys Sum
$217,300.00
Insider Sells Quantity
3
Insider Sells Sum
$89,491.91

Insider Activity of Notman Donald

According to the SEC Form 4 filings, Notman Donald, being in a position of

  1. Chief Financial Officer at Ocular Therapeutix, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 12645 shares for $62,034,
    over all time since 2017-12-07, has bought 39600 shares for $217,300, and sold 19121 share for $89,492.

The largest purchase of all time was on 2018-08-14 and amounted to 25000 shares of Ocular Therapeutix, Inc. for $157,250.

The largest sale of all time was on 2024-01-31 and amounted to 6433 shares of Ocular Therapeutix, Inc. for $31,843.

Biography of Notman Donald

No biography is available at this moment.

2024-02-05SaleOcular Therapeutix, Inc.
OCUL
Chief Financial Officer
6,212
0.0056%
$4.86$30,190+68.59%
2024-01-31SaleOcular Therapeutix, Inc.
OCUL
Chief Financial Officer
6,433
0.0059%
$4.95$31,843+70.37%
2023-02-06SaleOcular Therapeutix, Inc.
OCUL
Chief Financial Officer
6,476
0.0084%
$4.24$27,458+6.12%
2019-06-14PurchaseOcular Therapeutix, Inc.
OCUL
Chief Financial Officer
5,000
0.0115%
$4.33$21,650+3.43%
2018-08-14PurchaseOcular Therapeutix, Inc.
OCUL
Chief Financial Officer
25,000
0.0642%
$6.29$157,250-29.3%
2017-12-07PurchaseOcular Therapeutix, Inc.
OCUL
Chief Financial Officer
9,600
0.0332%
$4.00$38,400+55.11%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.